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Informed, advance refusals of treatment by
people with severe mental illness in a
randomised controlled trial of joint crisis
plans: demand, content and correlates
Claire Henderson1* , Simone Farrelly1, Clare Flach2, Rohan Borschmann1,5,6,7, Max Birchwood3,
Graham Thornicroft1, Waquas Waheed4 and George Szmukler1
Abstract
Background: In the UK, crisis planning for mental health care should acknowledge the right to make an informed
advance treatment refusal under the Mental Capacity Act 2005. Our aims were to estimate the demand for such
treatment refusals within a sample of service users who had had a recent hospital admission for psychosis or bipolar
disorder, and to examine the relationship between refusals, and service user characteristics.
Methods: To identify refusals we conducted content analysis of Joint Crisis Plans, which are plans formulated by service
users and their clinical team with involvement from an external facilitator, and routine care plans in sub-samples from a
multi-centre randomised controlled trial of Joint Crisis Plans (plus routine mental health care) versus routine care alone
(CRIMSON) in England. Factors hypothesised to be associated with refusals were identified using the trial data collected
through baseline interviews of service users and clinicians and collection of routine clinical data.
Results: Ninety-nine of 221 (45%) of the Joint Crisis Plans contained a treatment refusal compared to 10 of 424 (2.4%)
baseline routine care plans. No Joint Crisis Plans recorded disagreement with refusals on the part of clinicians. Among
those with completed Joint Crisis Plans, adjusted analyses indicated a significant association between treatment refusals
and perceived coercion at baseline (odds ratio = 1.21, 95% CI 1.02–1.43), but not with baseline working alliance or a past
history of involuntary admission.
Conclusions: We demonstrated significant demand for written treatment refusals in line with the Mental Capacity Act
2005, which had not previously been elicited by the process of treatment planning. Future treatment/crisis plans should
incorporate the opportunity for service users to record a treatment refusal during the drafting of such plans.
Trial registration: ISRCTN11501328 Registered 13th March 2008.
Background
Psychiatric crises, such as a relapse of psychosis, may be
associated with reduced decision-making capability [1].
In the United Kingdom (UK), health service users have
the right under the Mental Capacity Act (MCA) 2005 to
make an informed advance treatment refusal [2] when
capacitous, regarding times when their decision-making
capability is impaired. Advance refusals are legally bind-
ing, but may be overridden if the patient is subject to an
involuntary treatment order under the Mental Health
Act 1983, amended 2007 (MHA). People subject to the
MHA are given reasons for their detention and their
rights are explained at the point of detention. In the case
of advance refusals, an appropriate point at which to in-
form service users of the legal right to make such a
refusal and help them to exercise it is during the process
of crisis planning for mental health care.
In the national Health Service (NHS) mental health
services in England, a written crisis plan is routinely
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present in the care plan, and is written and updated
through the Care Programme Approach (CPA) [3]. This
provides the current benchmark for written crisis plans.
An audit of CPA forms showed very few documented re-
fusals, at just 2.4% of a sample of 424 crisis plans [4]. In
contrast, studies of both facilitated psychiatric advance
directives (f-PADs) in the US [5, 6] and Joint Crisis Plans
(JCPs) in the UK [7, 8] show much higher rates of re-
fusals, at around three quarters of participants complet-
ing a f-PAD [5] or JCP [8]. These are structured research
interventions in which an independent mental health
professional facilitates a discussion about preferences for
future care - including treatment refusals - with the ser-
vice user and, in the case of the JCP, with professionals
involved in his or her care [9]. The discrepancy between
these interventions and routine care plans suggests that
if service users are given better information about their
rights, more would make advance refusals. However, the
previous studies in the UK occurred before the MCA
2005 was introduced, so it is not clear whether the situ-
ation concerning refusals has changed. One trial con-
ducted since the introduction of the MCA 2005 of JCPs
for outpatients with borderline personality disorder [10]
showed a very high (90.2%) rate of refusals, but no com-
parison with the rate of refusals in the conventional
treatment plan was made.
We therefore made use of data from a recent multisite
trial of JCPs [11–13] that incorporated and explained
the relevant provision in the MCA. Our first aim was to
ascertain whether - and to what extent - the JCP process
elicited more written advance treatment refusals than
the CPA process during the process of a pragmatic ran-
domised controlled trial. Our second aim was to explore
the nature of such refusals and the relationships between
making a refusal with service user characteristics.
To address the first aim we tested the hypothesis that
the rate of refusals would be higher in JCPs than in CPA
treatment plans. To address the second aim we tested
the following hypotheses: (1) the majority of refusals will
be accepted by clinicians without concerns that they will
reduce the standard of care provided/received [6]; (2) re-
fusals are more likely to be made by participants who ei-
ther a) have prior experience of coercion i.e. transport or
detention under the Mental Health Act; b) report a high
level of perceived coercion at baseline; or c) report poor
working alliance with professionals at baseline. All of
these factors may indicate a lack of acceptance of at least
some aspects of treatment and hence a wish to avoid
these treatment components in future.
Methods
Setting and sample
The sample for this study is a sub-sample from the
CRIMSON trial [11–13]. The CRIMSON trial was a
multi-site randomised controlled trial of JCPs for indi-
viduals with psychotic disorders in four mental health
Trusts (NHS service provider organisations) in the UK
(total n = 569). The eligibility criteria for the CRIMSON
trial were: diagnosis of a psychotic disorder; admission
to a psychiatric ward in the last two years and current
contact with a community mental health team. Service
users who were in hospital or under a section of the
Mental Health Act at the time of recruitment were
deemed ineligible so as to avoid any potential perceived
coercion to participate. No other exclusions were made,
thus maximising generalisability. This study uses data
from three overlapping study samples: (1) intervention
group participants who completed the JCP process
(n = 221) and whose JCP could therefore be assessed
for refusals; and (2) the 424 patients whose CPA care
plans were available for assessment for treatment re-
fusals at baseline; and (3) those in the control group
whose CPA care plans were available at baseline and
follow up (n = 221).
The intervention
The JCP [7, 14] was developed in the later 1990’s. The
starting point was a review of existing models containing
information about the service user and requests for
treatment during a relapse or crisis [14]. Sections were
then added to encourage reflection about past crises that
would help inform the thinking and planning for future
crises. Headings were included where circumstances or
triggers for past relapses could be recorded, as well as
details of early signs of relapse and space to record both
the good and bad aspects of care received during previ-
ous crises. These headings precede the advance planning
section so that during the meeting to finalise the plan
these aspects are discussed. Eliciting this information
promotes a process of shared decision making at the
planning meeting, as the treating clinicians are present
and can also share their observations of early warning
signs, triggers, and what has been helpful/not helpful in
the past [15]. The completed JCP contains the service
user’s statements about past treatment and preferences
for care in the event of a future relapse or crisis. It was
produced after two meetings. At the first meeting, the
JCP facilitator - a member of the research team inde-
pendent of the clinical team - explained the procedure
to the service user and the care coordinator. To finalise
each plan, the service user was encouraged to bring a
carer, friend, or advocate to a second meeting. The aim
of this meeting was to discuss the views of the service
user, his or her informal supports(s) and treating profes-
sionals regarding what to do in a future crisis, and to ne-
gotiate agreed solutions. The JCP facilitator’s role was to
ensure that everyone’s perspective was heard but the
final choice of what was included in the plan (including
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the exact terminology used) lay with the service user.
The clinical team was present to discuss options and the
implications of the service user’s choice. When the op-
tion of stating which treatment(s) they did not want to
receive in future was discussed, the facilitator explained
the MCA 2005 provision for making a treatment refusal.
All JCPs were written in the first person to reflect the
service user’s own description of their mental health
issue and wishes for treatment. At the end of this meet-
ing the JCP facilitator asked clinicians if they were happy
to agree to the overall plan, in order to clarify to the ser-
vice user any content that they thought could not be
followed and have this acknowledged on the JCP.
After finalising the JCP, service users were given a
copy and an electronic version of the plan was stored on
the Trust’s electronic patient record system. Once com-
pleted, the content of the JCP could be updated by ser-
vice user and the regular clinical team and used in
routine care planning. The intervention group received
the JCP intervention in addition to treatment as usual
(described below). As the unit of randomisation was the
service user, some individual care coordinators and indi-
vidual doctors may have developed more than one JCP.
Likewise, some individual care coordinators and doctors
may have had service users in both the control and
intervention groups.
Treatment as usual control
The control condition was Treatment As Usual as stipu-
lated under the CPA. Treatment As Usual under the
CPA includes requirements that all service users are
assessed, receive a written care plan that includes a crisis
and contingency plan, and that this is reviewed regularly.
In most situations, service users have a nominated Care
Coordinator, whose role is to be the central point for
communication regarding the service user and to ensure
the service user’s identified health and social care needs
are met. Treatment As Usual thus in theory allows
the making of refusals and their documentation on
the CPA form by the Care Coordinator, although the
form may not specifically prompt them to do so.
Thus, the control condition not only lacks the
process of facilitation but also depends on existing
documentation required by the service.
Assessments
Assessment for treatment refusals and whether clinicians
would not be able to follow them: Refusals were assessed
in both the JCPs and CPA care plans. A content analysis
of the JCPs was conducted by SF. Refusals were coded
as present or not present, and content of refusals was
thematically coded [16]. For refusals on the CPA care
plan, the entire CPA care plan was printed and anon-
ymised by research assistants. SF assessed the content of
each plan at baseline and follow-up for the presence of
treatment refusals and for the presence of statements by
clinicians about any aspect of the JCP that they thought
could not be followed/adhered to.
Demographics: Research assistants collected demo-
graphic data from service users and Care Coordinators
including age, sex, ethnicity, education/qualification and
number of years in contact with mental health services.
For Care Coordinators, length of psychiatric practice
and length of relationship with the service user were also
collected.
Hospitalisations: Data regarding psychiatric admissions
in the two years prior to baseline and over the follow-up
period including duration and admission status (formal/
informal) were collected by research assistants from rou-
tine Trust data sets and corroborated by service users
and clinicians at interview.
Self-harm and harm to others: At baseline interview
participants were asked about instances and severity
of self-harm, suicide attempts and harm to others in
the two years prior to baseline and, at follow-up, they
were asked about the period since baseline assessment
(usually 18 months).
Objective Coercion: use of the Mental Health Act to
transport the service user or detain them in a psychiatric
unit.
Perceived Coercion: was measured by the perceived co-
ercion subscale of the service user self-report measure
the MacArthur Perceived Coercion Scale [17], adapted
for use in outpatient treatment. Higher scores indicate
more perceived coercion.
Therapeutic Relationships: The Working Alliance In-
ventory short form (WAI-S) [18, 19] modified for use in
psychiatric samples [20] was rated by service users and
clinicians (WAIC and WAIT respectively) at baseline
and follow-up.
Engagement: was measured by the Service Engagement
Scale (SES) [21]. This is a 14-item scale producing four
subscales measuring ‘availability’, ‘collaboration’, ‘help
seeking’ and ‘treatment adherence’ and a total score.
Higher scores on this measure indicate poorer engage-
ment. This measure was rated by the Care Coordinator.
Data analysis
To assess the proportion of refusals not identified
through the CPA process we compared the proportion
of refusals in the 221 completed JCPs with that in CPA
forms available: (1) at baseline for the entire group (n =
424); and (2) at follow-up for the control group only
(n = 203), as the presence or absence of a refusal in a
JCP could influence whether it was present in the partic-
ipants’ CPA form at follow-up. The analyses aimed at
identifying factors associated with refusals were
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restricted to the JCP group as it was only in this group
that there was a sufficient number.
Associations between covariates and missing data re-
garding treatment refusal were investigated using chi-
squared and t-tests as appropriate. Covariates found to
be associated with missing data were accounted for in all
analyses. Chi-squared analyses and t-tests were per-
formed to ascertain any relationships between making a
refusal and baseline service user clinical or demographic
characteristics based on bivariate analysis. The hypothe-
sised factors associated with a refusal were: previous
compulsory admissions, perceived coercion and service
user-rated working alliance at baseline. These were
regressed on an indicator of refusal of treatment using
logistic regression. The logistic regression model was ad-
justed for covariates associated with missing information
or treatment refusal.
Results
Rates of refusals in the CPA forms versus JCPs
Of the total sample for the CRIMSON trial (n = 569, 284
control, 285 intervention), 424 (74%) CPA forms were
available (221 controls and 203 intervention). We were
unable to obtain records from one Trust (n = 48). The re-
mainder were missing due to: not being able to locate a
care plan at baseline or follow-up (n = 52); participants be-
ing discharged at follow-up (n = 22) or downgraded to
care support and thus no care plan (n = 8); deaths (n = 5);
and refusing access to records (n = 10). Ten of these 424
CPA forms (2.4%) included refusals at baseline. For the
control group, six of the 221 (2.7%, 95% CI 1.0%–5.8%) in-
cluded a refusal at follow-up on their CPA forms. In the
intervention group 221/285 (77%) completed a JCP. Of
these, 99 (45%, 95% CI 38%–52%) made a refusal as part
of the JCP.
Agreements with JCPs by clinicians
There were no cases where clinicians explicitly disagreed
with the final version of the JCP.
Types of refusal
Based on the JCP sample, the most common refusal was
regarding aspects of medication: 45/99 (45%) made a re-
fusal of a specific medication (with 53% of this sub-
sample providing a reason for this refusal); 20/99 (20%)
refused injections. Others made refusals regarding high
doses of medication, increases or changes to dose. Only
one participant stated that they would prefer not to take
any medication. Seventeen refusals regarding specific
medications were made: one anti-cholinergic, three dif-
ferent mood stabilisers, two anti-depressants, one anti-
anxiolytic and ten anti-psychotics.
The most frequently refused anti-psychotics were:
haloperidol (n = 9), olanzapine (n = 8), risperidone (n = 5),
zuclopenthixol (n = 5), quetiapine (n = 4) and chlorpro-
mazine (n = 4). The next most common category of
refusal was electro-convulsive therapy (ECT; 19/99 (19%).
Eighteen participants (18%) made refusals relating to
admission to hospital. Of these, eight (44%) made refusals
about specific aspects of admission, such as which ward
they were admitted to. The remaining ten (56%) refused
hospital admission, though seven added a caveat, for
example, “[I refuse] being put in hospital. I know that this
is sometimes necessary however I would like this to be
the last resort”. While these caveats reflect acknowledge-
ments of the views of clinicians, there was no indication
on the other three as to whether clinicians disagreed with
these refusals.
Predictors of refusal
Sixty-four (22%) of participants in the JCP arm did not
complete a JCP. These participants were similar in most
respects to those who did, but tended to have had more
psychiatric admissions in the two years prior to the trial,
have a higher engagement with care (SES) score and
higher clinician-rated working alliance (WAIT). We
therefore adjusted further analyses for the number of ad-
missions, SES and WAIT score to account for bias due
to missing data.
Table 1 describes the sample with JCP refusal informa-
tion by refusal status. Treatment refusal was individually
associated with the participant’s location, ethnicity, years
in contact with mental health services and the perceived
coercion subscale of the McArthur coercion scale before
adjustments. There was no bivariate association between
having had an involuntary admission in the two years
prior to baseline assessment or service user-rated work-
ing alliance and treatment refusal.
Logistic regression of the refusal status on the three
hypothesised baseline predictors (involuntary admission,
perceived coercion and therapeutic alliance) adjusting
for site, ethnicity, contact with services and covariates
associated with missingness (SES, number of admissions
and carer-rated working alliance) are provided in Table 2.
The results indicate that there is no association between
working alliance or involuntary admission and advance
treatment refusals. The association between perceived
coercion and advance refusals remains significant when
other factors are accounted for (odds ratio = 1.34, 95%
CI 1.07–1.69, p = 0.013). Table 2 also shows that partici-
pant location remains associated with advance refusals
after adjustment for other factors.
Discussion
Summary of findings
Comparison of the rates of advance refusals made in
JCPs with those made in CPA forms among trial partici-
pants shows that the potential demand for refusals is
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barely addressed by the current CPA process used in
routine care. Our results also suggest that most refusals
made using the JCP were not out of keeping with what
the clinicians viewed as safe clinical practice. In no cases
did clinicians attending the JCP meetings disagree with
the refusals made, although it should be noted that this
does not mean all refusals were then followed in prac-
tice. It is also possible that clinicians did not voice their
concerns during the meetings (despite being asked for
their views by the facilitator), as suggested by qualitative
interviews of some participating clinicians [22]. They
may instead have wanted to avoid an argument with the
service user and/or have judged the process to be non-
binding. Thus, knowing that refusals made under the
Mental Capacity Act 2005 can be overridden using the
Mental Health Act may reduce the attention paid by cli-
nicians to refusals made by serviced users, despite the
possibility of honouring a refusal (such as that of a par-
ticular medication) while someone is detained under the
Mental Health Act. Among those who received a JCP,
higher perceived coercion at baseline was associated
with subsequent treatment refusal, as hypothesised.
However, no association was found with having a previ-
ous involuntary admission or working alliance and sub-
sequent treatment refusal.
The association with duration of contact with mental
health services, along with the lack of association with
involuntary admission or working alliance, suggests that
many refusals are made based on experiences of treat-
ments regardless of whether these were experienced
Table 1 Description of the JCP sample at baseline by refusal status
Variable Category Value Total N = 221 Treatment Refusal N = 99 p-value
Site London 77 18 (23%)
Birmingham 75 42 (56%)
Manchester/Lancashire 69 39 (57%) < 0.001
Sex Male 113 48 (42%)
Female 108 51 (52%) 0.398
Age mean (sd) 40.4 (11.5) 41.2 (11.6) 0.375
Ethnicity (grouped) White-all 141 76 (54%)
Black/Black British - all 51 13 (25%)
Other 29 10 (35%) 0.001
Education None 65 31 (48%)
School 103 41 (40%)
Vocational 24 14 (58%)
Higher 27 12 (44%) 0.386
Diagnosis OPCRIT groupeda Schizophrenia spectrum disorders 162 70 (43%)
Affective disorders 59 29 (49%) 0.432
Clinical measures over last two years
Number of admissions mean (sd) 1.47 (0.92) 1.37 (0.71) 0.181
A formal Admission No 91 40 (44%)
Yes 130 59 (45%) 0.768
Self-harm No 175 81 (46%)
Yes 46 18 (39%) 0.385
Suicide attempt No 162 73 (45%)
Yes 59 26 (44%) 0.895
Harm to others No 196 88 (45%)
Yes 23 10 (43%) 0.897
Years in contact with MHS mean (sd) 14.6 (9.4) 16.0 (9.9) 0.041
Perceived Coercion (MacArthur) 2.25 (1.6) 2.54 (1.5) 0.016
Engagement with care (SES) 9.21 (6.9) 8.74 (6.8) 0.397
Therapeutic relationship: Self-rated (WAIC) 15.8 (6.3) 16.2 (6.3) 0.404
Therapist-rated (WAIT) 16.7 (5.0) 17.0 (5.2) 0.483
a OPCRIT [31]
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while detained under the Mental Health Act. Participant
location at the sites outside London was also associated
with treatment refusal. This may indicate differences in
implementation of the JCP development process among
the sites on the part of the facilitators, despite the
provision of supervision of all facilitators by the same
member of the research team. A second possibility is the
existence of site level differences in participants’ past ex-
periences of treatment, which were not captured in the
assessment and exclude use of the Mental Health Act
per se, but which give rise to higher rates of treatment
refusal.
Limitations of the study
While the JCP intervention allowed us to assess demand
for treatment refusals and their relationship with clinical
and demographic factors, the sample was subject to the
eligibility criteria for the CRIMSON trial. This took
place in three urban and one rural area within the three
sites and included only those with an admission in the
last two years; the sample is therefore not fully represen-
tative of adults with psychoses using secondary mental
health services in England. Further, we are unable to re-
port the extent to which refusals were honoured due to
the CRIMSON trial resource limitations.
Conclusions
Our findings are consistent with previous research
showing there is strong demand for psychiatric ad-
vance statements [23–25] and that the content of
most advance statements can be followed without
compromising care [6, 25, 26]. However, most of
those who want to make a statement need support to
complete it [5, 27], and despite the existence of UK
legislation for advance refusals, services offer no sys-
tematic or efficient way of providing this support. We
have thus highlighted an aspect of the Mental Cap-
acity Act 2005 which has been under-implemented in
mental health services. The creation of, access to, and
honouring of individualised crisis plans which include
refusals are important in their own right but are
missing from current care pathways [4].
The research evidence is clear that interventions
such as Joint Crisis Plans and facilitated psychiatric
advance directives are an effective way to inform ser-
vice users of their legal rights to make advance treat-
ment refusals; they probably also improve working
alliance with clinicians [13, 24]. Evidence that these
interventions can lead to ‘harder’ outcomes such as
reduced use of involuntary treatment [28] and for
their cost-effectiveness [12, 29] is more mixed, and
may reflect problems in implementation.11 However, a
recent systematic review identified advance statements
as the only intervention associated with reduction in
the use of compulsory treatment [28]. Further work is
needed to identify ways to overcome barriers to the
creation of advance statements, together with study of
the outcomes associated with not just their creation
but of their application in routine practice.
Recently arguments have been presented that involun-
tary detention and treatment under mental health legis-
lation be like that for general health care, that is, based
on impaired decision-making capacity and best interests
[30]. In such a case, a treatment refusal could not be
‘trumped’ by mental health legislation. If the law were to
be reformed, the patient’s decision-making capacity
would need to be assured, especially when a treatment
refusal with serious health consequences was desired.
The place of a state’s duty to protect life, as under the
European Convention on Human Rights, might need to
be considered. The impact of legal reform on the imple-
mentation of support for service users to make advance
statements, which may include refusals, is not clear.
Table 2 Hypothesised baseline predictors of treatment refusal within the JCP treatment arm, adjusted for covariates listed, n = 168
Covariate Odds Ratio 95% Confidence Interval p-value
Formal admission 1.42 0.65 3.11 0.383
Perceived Coercion 1.34 1.07 1.69 0.013
Therapeutic relationship service user-rated (WAIC) 1.00 0.94 1.06 0.877
Number of admissions in past 2 years 0.84 0.55 1.28 0.409
Engagement with care (SES) 0.95 0.89 1.02 0.154
Therapeutic relationship clinician-rated (WAIT) 1.02 0.93 1.12 0.687
Site: Birmingham vs. London 6.19 2.37 16.19 < 0.001
Manchester/Lancashire vs. London 5.94 2.19 16.12 < 0.001
Ethnicity: Black/Black British vs. White 0.57 0.20 1.67 0.307
Other vs. White 0.54 0.19 1.56 0.255
Years in contact with MHSa 1.04 1.00 1.08 0.060
amental health services
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